Exozymes CSO converts 32,964 RSUs to shares
Rhea-AI Filing Summary
EXOZYMES INC. (EXOZ) reported that Chief Scientific Officer Korman Tyler Paz exercised 32,964 Restricted Stock Units into 32,964 shares of Common Stock on August 19, 2026. The RSUs convert on a one-for-one basis. Following these transactions, Paz directly holds 762,837 shares of Common Stock and 46,140 RSUs (derivative securities).
Positive
- None.
Negative
- None.
Insider Trade Summary
32,964 shares exercised/converted
Exercise
2 txns
Insider
Korman Tyler Paz
Role
Chief Scientific Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Unit F1, F2 | 32,964 | $0.00 | $0.00 |
| Exercise | Common Stock F1 | 32,964 | -- | -- |
Holdings After Transaction:
Restricted Stock Unit — 46,140 contracts (Direct);
Common Stock — 762,837 shares (Direct)
Footnotes (2)
- F1. The RSU convert on a one-for-one basis.
- F2. On March 28, 2022, and May 1, 2023, the reporting person was granted an aggregate of 79,104 RSUs, vesting periodically. The first vesting was August 19, 2026, in the amount of 32,964 shares of common stock.
Key Figures
RSUs exercised: 32,964 shares
Common Stock acquired: 32,964 shares
Common Stock holdings after transaction: 762,837 shares
+3 more
6 metrics
RSUs exercised
32,964 shares
Restricted Stock Units converted into Common Stock on August 19, 2026
Common Stock acquired
32,964 shares
Shares received upon exercise/conversion of RSUs on August 19, 2026
Common Stock holdings after transaction
762,837 shares
Direct ownership following the August 19, 2026 transactions
RSU holdings after transaction
46,140 units
Derivative securities remaining after 32,964 RSUs converted one-for-one
Aggregate RSU grants
79,104 RSUs
Granted on March 28, 2022 and May 1, 2023, vesting periodically
First vesting amount
32,964 shares
First vesting on August 19, 2026 from the aggregate RSU grants
Key Terms
Restricted Stock Unit, derivative security, vesting
3 terms
Restricted Stock Unit financial
"The RSU convert on a one-for-one basis."
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
derivative security financial
"Exercise or conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
vesting financial
"RSUs, vesting periodically. The first vesting was August 19, 2026"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
FAQ
What insider transaction did EXOZ (EXOZYMES INC.) report for Korman Tyler Paz?
EXOZ reported that Chief Scientific Officer Korman Tyler Paz exercised 32,964 RSUs into 32,964 shares of Common Stock on August 19, 2026, as part of previously granted equity awards vesting periodically.
How many Restricted Stock Units does Korman Tyler Paz still hold in EXOZ (EXOZ)?
Following the reported RSU conversion, Korman Tyler Paz holds 46,140 Restricted Stock Units, each convertible into one share of EXOZYMES INC. Common Stock.
What was the size of the RSU grant mentioned in the EXOZ Form 4 filing?
The filing states that on March 28, 2022, and May 1, 2023, Korman Tyler Paz was granted an aggregate of 79,104 RSUs, vesting periodically, with the first vesting on August 19, 2026 for 32,964 shares of common stock.
Was the EXOZ insider transaction reported as a market buy or sell?
No market buy or sell was reported. The Form 4 describes an exercise or conversion of derivative securities (RSUs) into common stock, with no per-share purchase or sale price reported.
AI-generated analysis. How Rhea-AI works. Not financial advice.
